Delivery Order SPE2DB24D2101-SPE2DB25FKPEQ
- Not listed
- The Defense Logistics Agency awarded a $46,511 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes, with an ultimate completion date of September 25, 2025. This competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This delivery order, awarded August 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides LEQVIO 284 mg/1.5 mL syringes valued at $9.3K with a completion date of August 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting open and competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The $4,394.82 firm fixed-price contract has a completion date of September 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,894 units of the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The $13,184.46 delivery order has a completion date of January 31, 2024. Amerisourcebergen Drug Corp has a longstanding relationship with DLA Troop Support Medical as a prime contractor providing pharmaceuticals, medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medication, with a ceiling value of $13,953.30 and a performance period ending on May 21, 2025. This contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a potential value of $2,197.41 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S. government...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,883.25 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a ceiling value of $4,651.10 and a completion date of July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $4,651.10. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 16, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $13,018.86 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562055006 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania under firm fixed pricing by September 26, 2023. The contract supports the Defense Logistics Agency's mission to provide medical supplies to the U.S....
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPEQDelivery Order
The Defense Logistics Agency awarded a $13,953.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability in federal medical procurement through its extensive portfolio of pharmaceutical product deliveries. The company's DLA Troop Support Medical contract encompasses a broad spectrum of medications and medical supplies across multiple therapeutic domains, including specialty drugs, vaccines, and medical devices. This delivery order for LEQVIO, a prescription pharmaceutical product, exemplifies the company's ongoing role in supplying critical medications to support Defense Health Agency and broader military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 9/4/25 |